IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.198
NA - Nord America 1.542
EU - Europa 557
SA - Sud America 117
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 7
Totale 6.466
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.368
US - Stati Uniti d'America 1.483
CN - Cina 364
IT - Italia 280
HK - Hong Kong 152
BD - Bangladesh 146
GB - Regno Unito 80
BR - Brasile 64
FR - Francia 56
VN - Vietnam 42
DE - Germania 38
IN - India 27
CA - Canada 25
FI - Finlandia 19
MX - Messico 18
NL - Olanda 17
CZ - Repubblica Ceca 15
AR - Argentina 13
TR - Turchia 13
PL - Polonia 12
MY - Malesia 11
SA - Arabia Saudita 10
VE - Venezuela 10
CO - Colombia 9
ID - Indonesia 9
ZA - Sudafrica 9
ES - Italia 7
IQ - Iraq 7
PE - Perù 7
PH - Filippine 7
UA - Ucraina 7
CL - Cile 6
AU - Australia 5
NP - Nepal 5
PK - Pakistan 5
RU - Federazione Russa 5
SE - Svezia 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
JP - Giappone 4
KE - Kenya 4
CR - Costa Rica 3
EC - Ecuador 3
HN - Honduras 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GN - Guinea 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.449
Salva come PNG Salva come JPEG
Città #
San Jose 323
Ashburn 278
Singapore 258
Rome 156
Hong Kong 147
Beijing 122
Hefei 103
Dallas 77
Council Bluffs 70
Boardman 55
Columbus 55
London 50
Phoenix 50
Santa Clara 49
Lauterbourg 42
Shanghai 36
Los Angeles 29
New York 27
Munich 25
Ho Chi Minh City 18
Seattle 18
Buffalo 17
Brno 15
San Francisco 14
São Paulo 14
Mexico City 13
Naples 11
Turku 11
Amsterdam 10
Warsaw 10
West Jordan 10
Boston 9
Washington 9
Helsinki 8
Milan 8
Las Vegas 7
Toronto 7
Hanoi 6
Orem 6
Pune 6
Verona 6
Brooklyn 5
Guangzhou 5
Johannesburg 5
Manchester 5
Montreal 5
Paris 5
Sona 5
Bangkok 4
Bogotá 4
Bologna 4
Chennai 4
Jeddah 4
Lima 4
Nairobi 4
Secaucus 4
Stockholm 4
Caracas 3
Charlotte 3
Chicago 3
Frankfurt am Main 3
Genoa 3
Haiphong 3
Krasnodar 3
Kuala Lumpur 3
Lahore 3
Melbourne 3
Memphis 3
New Orleans 3
Palermo 3
Philadelphia 3
Richmond 3
Riyadh 3
San Pedro Sula 3
Tokyo 3
Uberlândia 3
Acalanes Ridge 2
Allentown 2
Atlanta 2
Augusta 2
Bari 2
Barquisimeto 2
Basra 2
Boydton 2
Brasília 2
Brownsville 2
Cagliari 2
Cairo 2
Camden 2
Canberra 2
Cape Town 2
Central 2
Cosenza 2
Dammam 2
Dhaka 2
Dnipro 2
Florence 2
Garland 2
Goiânia 2
Hamilton 2
Totale 2.361
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 266
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 255
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 249
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 242
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 240
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 239
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 236
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 232
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 229
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 222
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 220
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 214
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 213
Assessment of liver function by the exhaled breath-print during chronic liver disease 210
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 181
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 177
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 151
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 143
Diabetes in chronic liver disease: from old concepts to new evidence 141
A challenging alfa-fetoprotein in a cirrhotic patient 139
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 129
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 128
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 122
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 120
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 117
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 102
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 82
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 82
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 80
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 80
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 78
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 77
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 76
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 71
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 67
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 67
Hepatic complications of bariatric surgery : the reverse side of the coin 61
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 61
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 58
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 58
Surgical complications after resection of adrenal carcinoma 55
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 54
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 53
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 52
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 50
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 49
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 49
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 48
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 48
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 48
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 45
Totale 6.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202279 0 0 0 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/20262.008 169 81 112 145 83 110 513 116 139 180 220 140
2026/2027577 43 205 269 60 0 0 0 0 0 0 0 0
Totale 6.466